Search

Author/Creator Yang, Yong‐Feng

1. A phase 3, open‐label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin. Issue 11 (November 2016)

Authors:
Wei, Lai; Zhang, Mingxiang; Xu, Min; Chuang, Wan‐Long; Lu, Wei; Xie, Wen; Jia, Zhansheng; Gong, Guozhong; Li, Yueqi; Bae, Si Hyun; Yang, Yong‐Feng; Xie, Qing; Lin, Shumei; Chen, Xinyue; Niu, Junqi; Jia, Jidong; Garimella, Tushar; Torbeyns, Anne; McPhee, Fiona; Treitel, Michelle
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 31:Issue 11(2016:Nov.)
Page Start:
1860
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3‐9 homolog 1 and SET domain containing 1A histone methyltransferases. Issue 4 (25th July 2018)

Authors:
Ren, Ji‐Hua; Hu, Jie‐Li; Cheng, Sheng‐Tao; Yu, Hai‐Bo; Wong, Vincent Kam Wai; Law, Betty Yuen Kwan; Yang, Yong‐Feng; Huang, Ying; Liu, Yi; Chen, Wei‐Xian; Cai, Xue‐Fei; Tang, Hua; Hu, Yuan; Zhang, Wen‐Lu; Liu, Xiang; Long, Quan‐Xin; Zhou, Li; Tao, Na‐Na; Zhou, Hong‐Zhong; Yang, Qiu‐Xia
Journal:
Hepatology
Issue:
Volume 68:Issue 4(2018)
Page Start:
1260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗